eprocliv 50 mg/1000 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
maymetsi 50 mg/850 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
maymetsi 50 mg/850 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
maymetsi 50 mg/1000 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
maymetsi 50 mg/1000 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
maymetsi 50 mg/850 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
maymetsi 50 mg/850 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
eprocliv 50 mg/1000 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin
eprocliv 50 mg/850 mg filmsko obložene tablete
metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin